Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoyuki Koshi is active.

Publication


Featured researches published by Tomoyuki Koshi.


Bioorganic & Medicinal Chemistry Letters | 2001

Synthesis and bioactivities of novel pyridazine derivatives: inhibitors of interleukin-1 beta (IL-1β) production

Takayuki Matsuda; Taro Aoki; Tadaaki Ohgiya; Tomoyuki Koshi; Masao Ohkuchi; Hiromichi Shigyo

New pyridazine derivatives were prepared, and their abilities to inhibit IL-1beta production were evaluated. Some compounds showed potent inhibitory activity against IL-1beta production in HL-60 cells stimulated with lipopolysaccharide (LPS). The synthesis and structure-activity relationships of these compounds are described.


Bioorganic & Medicinal Chemistry Letters | 2001

Synthesis and bioactivities of novel 5,6-bis(4-methoxyphenyl)2H-pyridazin-3-one derivatives : Inhibitors of interleukin-1 beta (IL-1β) production

Takayuki Matsuda; Taro Aoki; Tomoyuki Koshi; Masao Ohkuchi; Hiromichi Shigyo

New 5,6-bis(4-methoxyphenyl)-2H-pyridazin-3-one derivatives were prepared, and their abilities to inhibit IL-1beta production were evaluated. Some compounds showed potent inhibitory activity against IL-1beta production in HL-60 cells stimulated with lipopolysaccharide (LPS). The synthesis and structure-activity relationships of these compounds are described.


Biochemical and Biophysical Research Communications | 1992

Characterization of immunoreactive endothelin in human urine

Koichi Arai; Tomoyuki Koshi; Yuriko Ehara; Toshiyuki Edano; Masao Ohkuchi; Mitsuteru Hirata; Tetsuro Okabe

We developed three antibodies, specific and sensitive to endothelin-1 (ET-1), and established two sandwich and three competitive enzyme immunoassays (EIAs). By using these EIAs, large immunoreactive ET (IR-ET) of molecular weight 10 k Da was identified as a main component of IR-ETs in human urine. This large IR-ET, which reacted with two antibodies specific for N-terminal region of ET-1 but not with the antibody against C-terminal peptide of ET-1, was partially purified by six-step procedure and examined by Western blotting after SDS polyacrylamide gel electrophoresis. The large IR-ET was detected as a single band at molecular weight of 10 k Da both in reduced and non-reduced conditions. From these results, the large IR-ET was thought to consist of a single polypeptide chain and possess the steric restricted N-terminal region of ET-1.


Biochemical and Biophysical Research Communications | 1992

Pyrogenic action of endothelin in conscious rabbit

Tomoyuki Koshi; Toshiyuki Edano; Koichi Arai; Chiyoka Suzuki; Yuriko Ehara; Mitsuteru Hirata; Masao Ohkuchi; Tetsuro Okabe

Injection of 0.3 nmol/kg endothelin(ET)-1 into the ear vein of conscious rabbits induced a significant increase in body temperature. ETB receptor specific agonist, namely 4-Ala-ET-1, also caused an elevation of the body temperature in a dose-dependent manner by injection into the ear vein of rabbit. These results suggest that ET play important roles in regulation of body temperature through selective stimulation of ETB receptor.


Bioorganic & Medicinal Chemistry Letters | 1994

Quantitative structure-activity relationships study of endothelin-1 analogs

Kiyoshi Hasegawa; Mitsuteru Hirata; Tomoyuki Koshi; Takeshi Ohshima; Yoshikatsu Miyashita; Shin-ichi Sasaki; Tetsuro Okabe

Abstract Endothelin-1 analogs replaced by various amino acids at position 20 [X20]-ET-1) were synthesized and evaluated for the ETA and ETB receptor binding activities. In order to obtain the structural requirements for the ETA and ETB receptor binding activities, the quantitative structure-activity relationships(QSAR) of sixteen analogs was investigated by the PLS method. The quantitative structuve-activity relationshis(QSAR) of endothelin-1 analogs([X20]-ET-1) replaced by various amino acids at position 20 was investigated by the PLS method.


Archive | 1999

Novel pyridazine derivatives and drugs containing the same as the active ingredient

Yuriko Habata; Takahiro Kitamura; Tomoyuki Koshi; Kyoko Kotaki; Yoshinori Kyotani; Takayuki Matsuda; Soichi Oda; Masao Ohkuchi; Hiromichi Shigyo; Hideo Yoshizaki


Journal of Lipid Research | 2004

A method of direct measurement for the enzymatic determination of cholesteryl esters

Toshimi Mizoguchi; Toshiyuki Edano; Tomoyuki Koshi


Archive | 1998

Pyridazine compounds and compositions containing the same

Masao Ohkuchi; Yoshinori Kyotani; Hiromichi Shigyo; Tomoyuki Koshi; Takahiro Kitamura; Tadaaki Ohgiya; Takayuki Matsuda; Yukiyoshi Yamazaki; Natsuyo Kumai; Kyoko Kotaki; Hideo Yoshizaki; Yuriko Habata


Chemical & Pharmaceutical Bulletin | 1991

Syntheses and Biological Activities of Endothelin-1 Analogs

Tomoyuki Koshi; Chiyoka Suzuki; Koichi Arai; Toshimi Mizoguchi; Takahiro Torii; Mitsuteru Hirata; Masao Ohkuchi; Tetsuro Okabe


Archive | 1998

Pyridazine derivatives and medicaments containing them as active ingredient

Yuriko Habata; Takahiro Kitamura; Tomoyuki Koshi; Kyoko Kotaki; Natsuyo Kumai; Yoshinori Kyotani; Takayuki Matsuda; Tadaaki Ohgiya; Masao Ohkuchi; Hiromichi Shigyo; Yukiyoshi Yamazaki; Hideo Yoshizaki

Collaboration


Dive into the Tomoyuki Koshi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge